Nipenesin (Guaifenesin)

Guaifenesin, the active ingredient in Nipenesin, is an expectorant presented as an oral dosage form for oral use. It helps relieve productive cough and chest congestion in adults and children.

GNH USA supplies Nipenesin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nipenesin is an expectorant used to manage conditions involving mucus accumulation in the respiratory tract.

Productive cough: Facilitates clearance of mucus, reducing cough frequency. Chest congestion: Helps thin secretions, easing breathing. Mucus accumulation: Improves expectoration in respiratory tract infections.

Guaifenesin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: Mild stomach upset may occur. - Vomiting: Occasional emesis reported. - Dizziness: Transient light‑headedness. - Headache: Mild to moderate headache. - Rash: Skin irritation or mild erythema. - Gastrointestinal discomfort: Stomach cramps or loose stools.

Serious or Rare Side Effects: - Allergic reaction: Hives, swelling, or difficulty breathing. - Anaphylaxis: Rare, severe hypersensitivity requiring emergency care. - Severe rash: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Bronchospasm: Worsening of breathing in susceptible individuals.

When using Nipenesin, consider the following safety measures.

Pregnancy: Consult a healthcare professional; safety data are limited. Breastfeeding: Use with caution; limited information on excretion in milk. Renal impairment: Monitor renal function; dosage adjustment may be required. Drug interactions: Review concomitant medications for potential interactions. Age considerations: Follow pediatric dosing recommendations if used in children. Store at ambient temperature: Keep in the original container, protect from moisture and heat.

Nipenesin may interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): May increase risk of hypertensive reactions. - Cough suppressants containing codeine: May reduce the expectorant effect.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: May increase dryness of secretions. - Diuretics: Potential for electrolyte imbalance if dehydration occurs. - Other mucolytics: May enhance gastrointestinal side effects.